S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
The #1 Crypto for 2024 (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
The A.I. story nobody is telling you (Read ASAP) (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
The #1 Crypto for 2024 (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
The A.I. story nobody is telling you (Read ASAP) (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
The #1 Crypto for 2024 (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
The A.I. story nobody is telling you (Read ASAP) (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
S&P 500   5,011.12
DOW   37,775.38
QQQ   423.41
What's Driving Tesla Lower Ahead of its Earnings?
The "Smart Money" Is Ready for May 1st Are You? (Ad)
Stock market today: Asian markets sink, with Japan’s Nikkei down 3.5%, as Mideast tensions flare
How major US stock indexes fared Thursday, 4/18/2024
The #1 Crypto for 2024 (Ad)
3 Steel Stocks Could Soar on New China Tariffs
CSX Co.: The Railroad Powering Ahead with an Earnings Beat
The A.I. story nobody is telling you (Read ASAP) (Ad)
These are the Top 4 Stocks for Buybacks in 2024
'There is no time to waste': EU leaders want to boost competitiveness to close gap with US and China
Free Trial
OTCMKTS:DCTHD

Delcath Systems (DCTHD) Stock Price, News & Analysis

→ The “Perfect Storm” for Gold (From Gold Safe Exchange) (Ad)
Free DCTHD Stock Alerts
Notice: This company has been marked as potentially delisted and may not be actively trading.
Compare
Today's Range
$4.26
▼
$5.03
50-Day Range
N/A
52-Week Range
$1.22
▼
$63,000.00
Volume
335,142 shs
Average Volume
771 shs
Market Capitalization
$187,800.00
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Stock AnalysisHeadlines
DCTHD stock logo

About Delcath Systems Stock (OTCMKTS:DCTHD)

Delcath Systems, Inc. is a late-stage clinical development company with early commercial activity in Europe focused on cancers of the liver. The Company is a specialty pharmaceutical and medical device company developing its product, Melphalan Hydrochloride for Injection for use with the Delcath Hepatic Delivery System (Melphalan/HDS). The Company's system delivers and filters melphalan hydrochloride, which is marketed as a device under the trade name Delcath Hepatic CHEMOSAT Delivery System for Melphalan (CHEMOSAT). The Company's focus is on the execution of the clinical development program (CDP) in ocular melanoma liver metastases (mOM), intrahepatic cholangiocarncinoma (ICC), hepatocellular carcinoma (HCC or primary liver) and other cancers that are metastatic to the liver.

DCTHD Stock News Headlines

March 21, 2024 | gurufocus.com
Director Gil Aharon Acquires 26,882 Shares of Delcath Systems Inc (DCTH)
December 30, 2023 | benzinga.com
Delcath Systems Stock (NASDAQ:DCTH) Insider Trades
April 18, 2024 | Gold Safe Exchange (Ad)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
December 30, 2023 | benzinga.com
Delcath Systems Stock (NASDAQ:DCTH) Dividends: History, Yield and Dates
August 31, 2023 | thestreet.com
Delcath Liver Tumor Data Improve
August 15, 2023 | msn.com
Delcath Systems (NASDAQ:DCTH) Skyrockets on FDA Approval for Hepzato Liver Therapy
August 11, 2023 | msn.com
Delcath Systems: HEPZATO KIT Should Receive Approval On Aug 14 PDUFA
August 9, 2023 | msn.com
Delcath Systems GAAP EPS of -$0.58 beats by $0.02, revenue of $0.5M misses by $0.24M
April 18, 2024 | Gold Safe Exchange (Ad)
The “Perfect Storm” for Gold
Gold has already reached all-time highs, and experts believe it's not slowing down any time soon. In fact, some analysts predict a $7,000 price tag by 2025.
July 9, 2023 | thestreet.com
Delcath Readies Pivotal Trial Results
June 19, 2023 | forbes.com
Best iPad POS Systems Of 2023
May 24, 2023 | msn.com
HC Wainwright & Co. Reiterates Delcath Systems (DCTH) Buy Recommendation
May 15, 2023 | bbc.co.uk
What is the digestive system?
May 12, 2023 | thestreet.com
Delcath: Safety Questions Behind FDA Delay
March 27, 2023 | finance.yahoo.com
Delcath Systems Announces up to $85 Million Financing
March 27, 2023 | markets.businessinsider.com
Delcath Systems Inc. Q4 Loss increases, misses estimates
March 27, 2023 | finance.yahoo.com
Delcath Systems Reports Fourth Quarter and Full Year 2022 Results and Provides Business Update
March 27, 2023 | markets.businessinsider.com
Delcath Announces FDA's Acceptance Of NDA Resubmission Of Hepzato Kit
February 16, 2023 | markets.businessinsider.com
Delcath Systems Announces Resubmission Of NDA For Hepzato Kit
December 15, 2022 | gurufocus.com
An Insider Just Bought Shares of Delcath Systems Inc; Could This Stock Be a Value Opportunity?
November 8, 2022 | seekingalpha.com
Delcath Systems slips despite Q3 beat
September 10, 2022 | seekingalpha.com
DCTH Delcath Systems, Inc.
August 10, 2022 | markets.businessinsider.com
Delcath Systems Inc. Q2 Loss increases, misses estimates
July 27, 2022 | markets.businessinsider.com
Delcath Systems to Host Second Quarter 2022 Results
March 15, 2022 | benzinga.com
Delcath Systems to Host Fourth Quarter and Full Year 2021 Results
February 4, 2022 | benzinga.com
Delcath's Chemosat Hepatic Delivery System Shows Overall Response Rate Of 60.5% In Eye Cancer That Spreads To Liver
December 2, 2021 | benzinga.com
Delcath Systems, Inc. Announces Positive Phase 3 FOCUS Trial Results for Hepzato™ in Liver-Dominant Metastatic Ocular Melanoma, Including Initial Survival Data Analysis
See More Headlines
Receive DCTHD Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Delcath Systems and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
11/11/2016
Today
4/18/2024
Get Stock Alerts

Industry, Sector and Symbol

Stock Exchange
OTCMKTS
Sector
Medical
Industry
Surgical & Medical Instruments
Sub-Industry
N/A
Current Symbol
OTCMKTS:DCTHD
Previous Symbol
NASDAQ:DCTH
CUSIP
N/A
CIK
N/A
Web
www.delcath.com
Phone
212-489-2100
Fax
N/A
Employees
N/A
Year Founded
N/A

Profitability

EPS (Most Recent Fiscal Year)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
$-19,220,000.00
Net Margins
-1,546.38%
Pretax Margin
N/A
Return on Equity
N/A
Return on Assets
-343.56%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.53
Quick Ratio
0.50

Sales & Book Value

Annual Sales
$3.41 million
Price / Sales
0.06
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($1,036.00) per share
Price / Book
0.00

Miscellaneous

Outstanding Shares
40,000
Free Float
N/A
Market Cap
$187,800.00
Optionable
Not Optionable
Beta
-0.03
10 Best Stocks to Own in 2024 Cover
10 Best Stocks to Own in 2024

Click the link below and we'll send you MarketBeat's list of the 10 best stocks to own in 2024 and why they should be in your portfolio.

Get This Free Report

Key Executives

  • Roger G. Stoll Ph.D. (Age 74)
    Chairman of the Board
  • Jennifer K. Simpson Ph.D. (Age 48)
    President, Chief Executive Officer, Director
  • Barbra C. Keck (Age 39)
    Chief Financial Officer, Secretary
  • John Purpura (Age 55)
    Executive Vice President - Global Head of Operations
  • Simon C. Pedder Ph.D. (Age 56)
    Director
  • William Dodge Rueckert (Age 64)
    Independent Director
  • Marco Taglietti M.D. (Age 57)
    Independent Director

Key Competitors

View All Competitors

DCTHD Stock Analysis - Frequently Asked Questions

How were Delcath Systems' earnings last quarter?

Delcath Systems, Inc. (OTCMKTS:DCTHD) announced its quarterly earnings results on Friday, November, 11th. The medical device company reported ($231.00) earnings per share for the quarter, topping analysts' consensus estimates of ($1,151.50) by $920.50. The medical device company had revenue of $0.44 million for the quarter. During the same quarter last year, the company posted ($686.00) earnings per share.

When did Delcath Systems' stock split?

Delcath Systems shares reverse split on Monday, November 6th 2017. The 1-350 reverse split was announced on Friday, November 3rd 2017. The number of shares owned by shareholders was adjusted after the closing bell on Friday, November 3rd 2017. An investor that had 100 shares of stock prior to the reverse split would have 0 shares after the split.

This page (OTCMKTS:DCTHD) was last updated on 4/18/2024 by MarketBeat.com Staff

From Our Partners
The “Perfect Storm” for Gold
Gold Safe Exchange
Biden’s $374B Giveaway Into This Sector
DTI
Biden replacement revealed?
Paradigm Press
He Is Giving Away Bitcoin
Crypto Swap Profits
Your Money is Not Safe
American Alternative
The #1 Crypto for 2024
InvestorPlace
Top 5 AI Stocks to Buy for 2024
Market Moving Trends
How Biden has already won 2024
Porter & Company